Homocysteine is a cardiovascular risk factor for the development of vascular pathology. Large population studies have been conducted demonstrating a positive association between homocysteine levels and risk of developing cardiovascular disease.Paradoxically in type 2 diabetes, if renal function is within a normal range, homocysteine levels are either similar or reduced when compared to levels in the normal non-diabetic population. Whether the same is true for pre-diabetes has not been previously explored.Our study examines the plasma levels of homocysteine in controls,and participants with prediabetes and diabetes from a screening program in regional New South Wales.
|Number of pages||1|
|Publication status||Published - 2013|
|Event||5th International Congress on Prediabetes and the Metabolic Syndrome: Early Interventions for Diabetes and Dysglycaemia - Vienna, Austria|
Duration: 17 Apr 2013 → 19 Apr 2013
|Conference||5th International Congress on Prediabetes and the Metabolic Syndrome|
|Abbreviated title||Surgery in the Treatment of Obesity and Diabetes|
|Period||17/04/13 → 19/04/13|